Literature DB >> 9105677

Functional coupling of the nociceptin/orphanin FQ receptor with the G-protein-activated K+ (GIRK) channel.

K Ikeda1, K Kobayashi, T Kobayashi, T Ichikawa, T Kumanishi, H Kishida, R Yano, T Manabe.   

Abstract

Nociceptin/orphanin FQ is a heptadecapeptide which was recently isolated from brains. It induces hyperalgesia, in contrast to the analgesic effects of opioid ligands, although it and its receptor structurally resemble opioid peptides and opioid receptors, respectively. To investigate the molecular mechanism underlying nociceptin/orphanin FQ actions, we performed Xenopus oocyte expression assays, in situ hybridization histochemistry and electrophysiological analyses of neurons. We found that the nociceptin/orphanin FQ receptor is functionally coupled with the G-protein-activated K+ (GIRK) channel in Xenopus oocytes, and that the receptor mRNA and GIRK1 mRNA co-exist in various neurons, including hippocampal pyramidal cells. Furthermore, we found that nociceptin/orphanin FQ induces hyperpolarizing currents via inward-rectifier K+ channels in hippocampal pyramidal cells, suggesting that the nociceptin/orphanin FQ receptor couples with the GIRK channel in this region. We conclude that the nociceptin/orphanin FQ receptor couples with the GIRK channel in various neurons, including hippocampal pyramidal cells, thereby modulating neuronal excitability.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9105677     DOI: 10.1016/s0169-328x(96)00252-5

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  24 in total

1.  Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms.

Authors:  M K Tallent; S G Madamba; G R Siggins
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

2.  [Nphe(1)]-Nociceptin (1-13)-NH(2), a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats.

Authors:  J P Redrobe; G Calo; R Guerrini; D Regoli; R Quirion
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  Nociceptin produces antinociception after spinal administration in amphibians.

Authors:  Craig W Stevens; Kristin K Martin; Brad W Stahlheber
Journal:  Pharmacol Biochem Behav       Date:  2008-09-05       Impact factor: 3.533

4.  Activation of membrane estrogen receptors attenuates opioid receptor-like1 receptor-mediated antinociception via an ERK-dependent non-genomic mechanism.

Authors:  K M Small; S Nag; S S Mokha
Journal:  Neuroscience       Date:  2013-10-24       Impact factor: 3.590

5.  Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac).

Authors:  Toru Kobayashi; Kazuo Washiyama; Kazutaka Ikeda
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

6.  The untranslated region of (mu)-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice.

Authors:  K Ikeda; T Kobayashi; T Ichikawa; T Kumanishi; H Niki; R Yano
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

7.  Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala.

Authors:  Marisa Roberto; George R Siggins
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-20       Impact factor: 11.205

8.  Inhibitory action of nociceptin/orphanin FQ on functionally different thalamic neurons in urethane-anaesthetized rats.

Authors:  D Albrecht; R Blühdorn; H Siegmund; H Berger; G Calo'
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

9.  Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ.

Authors:  Dirk Faulhammer; Bernd Eschgfäller; Sandra Stark; Petra Burgstaller; Werner Englberger; Jeannette Erfurth; Frank Kleinjung; Johanna Rupp; Sebastian Dan Vulcu; Werner Schröder; Stefan Vonhoff; Hermann Nawrath; Clemens Gillen; Sven Klussmann
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

10.  Nociceptin inhibits vanilloid TRPV-1-mediated neurosensitization induced by fenoterol in human isolated bronchi.

Authors:  Christophe Faisy; Emmanuel Naline; Céline Rouget; Paul-André Risse; Emmanuel Guerot; Jean-Yves Fagon; Thierry Chinet; Nicolas Roche; Charles Advenier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.